Go Pro
NASDAQ:ABP

Abpro Q3 2025 Earnings Report

Abpro logo
$0.52 0.00 (0.00%)
As of 08/28/2026

Abpro EPS Results

Actual EPS
-$0.63
Consensus EPS
-$1.20
Beat/Miss
Beat by +$0.57
One Year Ago EPS
N/A

Abpro Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Abpro Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Abpro Earnings Headlines

Abpro Holdings Faces Nasdaq Delisting, Moves to OTC
Abpro Holdings Directors Resign, Board Seeks Replacements
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
ABPO Abpro Holdings, Inc.
Abpro Bio Co. Ltd.
See More Abpro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abpro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abpro and other key companies, straight to your email.

About Abpro

Abpro (NASDAQ:ABP) is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

View Abpro Profile